Table 2.
Prevalence of men with localised prostate cancer and of control men who reported incontinence, bowel problems, or impotence at 15 years by initial treatment
| Condition and follow-up year | Participant group (type of treatment or control) (No who reported condition/Total No in group (%)) | ||||||
|---|---|---|---|---|---|---|---|
| AS/WW | NSRP | Non-NSRP | EBRT/HDR | ADT | LDR | Controls | |
| Urinary incontinence*: | |||||||
| Baseline | 12/200 (6.0) | 3/494 (0.6) | 7/478 (1.5) | 0/170 | 9/227 (4.0) | 0/58 | 5/495 (1.0) |
| 15 years | 6/53 (11.3) | 35/192 (18.2) | 38/141 (27.0) | 6/43 (14.0) | 5/45 (11.1) | 1/25 (4.0) | 0/103 |
| Moderate or severe bowel problems†: | |||||||
| Baseline | 27/200 (13.5) | 18/494 (3.6) | 25/478 (5.2) | 14/170 (8.2) | 21/227 (9.3) | 0/58 | 31/495 (6.3) |
| 15 years | 6/53 (11.3) | 12/192 (6.3) | 4/141 (2.8) | 6/43 (14.0) | 8/45 (17.8) | 0/25 | 2/103 (1.9) |
| Erectile dysfunction‡: | |||||||
| Baseline | 53/200 (26.5) | 76/494 (15.4) | 128/478 (26.8) | 47/170 (27.6) | 87/227 (38.3) | 11/58 (19.0) | 109/495 (22.0) |
| 15 years | 33/53 (62.3) | 144/192 (75.0) | 117/141 (83.0) | 34/43 (79.1) | 34/45 (75.6) | 18/25 (72.0) | 44/103 (42.7) |
ADT=androgen deprivation therapy with or without EBRT; AS/WW=active surveillance/watchful waiting; EBRT/HDR=external beam radiotherapy or high dose rate brachytherapy only (no androgen deprivation therapy); LDR=low dose rate brachytherapy; N/A=not available; non-NSRP=non-nerve sparing radical prostatectomy; NSRP=nerve sparing radical prostatectomy.
Incontinence is defined as needing to wear one or more pad per day owing to weak urinary control and frequent leakage.
Bowel problems are defined as participants’ responses to the question “Overall, how big a problem have your bowel habits been?” being either “moderate” or “big.”
Erectile dysfunction is defined as being unable to obtain an erection sufficient for penetrative intercourse.